These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7522000)
1. [Screening test for prostate cancer]. Imai K; Kubota Y; Yamanaka H Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000 [TBL] [Abstract][Full Text] [Related]
2. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen]. Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916 [TBL] [Abstract][Full Text] [Related]
3. [Screening examination for prostate cancer. Early detection and mass screening]. Imai K; Yamanaka H Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1175-87. PubMed ID: 7689120 [TBL] [Abstract][Full Text] [Related]
4. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822 [TBL] [Abstract][Full Text] [Related]
5. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer]. Watanabe M; Saitoh M; Watanabe H Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472 [TBL] [Abstract][Full Text] [Related]
6. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer]. Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749 [TBL] [Abstract][Full Text] [Related]
7. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group]. Imai K; Watanabe K; Higashi H; Shinya H; Okamura K; Matsuo Y; Yazima H; Takezawa Y; Yamanaka H Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709 [TBL] [Abstract][Full Text] [Related]
8. [Local screening program for prostate cancer]. Kotsev R; Kolev N; Stratev S; Mikhailov O Khirurgiia (Sofiia); 2000; 56(5-6):52-4. PubMed ID: 11692936 [TBL] [Abstract][Full Text] [Related]
9. An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population:experience in a Nigerian teaching hospital. Ojewola RW; Tijani KH; Jeje EA; Ogunjimi MA; Anunobi CC; Adesanya AO West Afr J Med; 2013; 32(1):8-13. PubMed ID: 23613288 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J J Urol; 1995 Sep; 154(3):1085-9. PubMed ID: 7543604 [TBL] [Abstract][Full Text] [Related]
11. Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen. Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M Tumori; 1995; 81(4):225-9. PubMed ID: 8540115 [TBL] [Abstract][Full Text] [Related]
12. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL. Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057 [TBL] [Abstract][Full Text] [Related]
13. [Detection of cancer of the prostate. A study of 600 cases]. Teillac P; Bron J; Tobolski F; Cussenot O; Lesourd A; Leroy M; Toubert ME; Brocheriou C; Laval-Jeantet M; Le Duc A Ann Urol (Paris); 1990; 24(1):37-41. PubMed ID: 1690963 [TBL] [Abstract][Full Text] [Related]
14. [Screening of cancer of the prostate: study in a Spanish population]. Herrero Payo JA; Montes Díaz MJ; Páez Borda A; Sánchez Sánchez E; Moreno Valle JA; Berenguer Sánchez A Arch Esp Urol; 1996; 49(6):595-606. PubMed ID: 8929102 [TBL] [Abstract][Full Text] [Related]
15. [Mass screening for prostatic cancer]. Nakagawa S; Watanabe M; Nomoto T; Sugimoto K; Mikami K; Ebisui K; Kitamura K; Kojima M; Saitoh M; Watanabe H Hinyokika Kiyo; 1997 Jun; 43(6):447-52. PubMed ID: 9250497 [TBL] [Abstract][Full Text] [Related]
16. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. Men S; Cakar B; Conkbayir I; Hekimoglu B J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069 [TBL] [Abstract][Full Text] [Related]
18. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases]. Kato M; Okada K Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140 [TBL] [Abstract][Full Text] [Related]
19. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. Presti JC; Carroll PR Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474 [TBL] [Abstract][Full Text] [Related]
20. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy]. Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]